Emanuele Andreano
Overview
Explore the profile of Emanuele Andreano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
862
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Johnson N, Wall S, Kramer K, Holt C, Periasamy S, Richardson S, et al.
Structure
. 2024 Sep;
32(11):1893-1909.e11.
PMID: 39326419
The continued emergence of deadly human coronaviruses from animal reservoirs highlights the need for pan-coronavirus interventions for effective pandemic preparedness. Here, using linking B cell receptor to antigen specificity through...
2.
Paciello I, Pierleoni G, Pantano E, Antonelli G, Pileri P, Maccari G, et al.
Cell Rep
. 2024 Aug;
43(9):114645.
PMID: 39207904
Understanding the evolution of the B cell response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants is fundamental to design the next generation of vaccines and therapeutics. We longitudinally...
3.
Paciello I, Maccari G, Pierleoni G, Perrone F, Realini G, Troisi M, et al.
Sci Immunol
. 2024 Aug;
9(98):eadp9279.
PMID: 39121195
The severe acute respiratory syndrome coronavirus 2 variant JN.1 recently emerged as the dominant variant despite having only one amino acid change on the spike (S) protein receptor binding domain...
4.
Severa M, Etna M, Andreano E, Ricci D, Cairo G, Fiore S, et al.
iScience
. 2024 May;
27(5):109703.
PMID: 38706870
Monoclonal antibodies (mAb) targeting the SARS-CoV-2 Spike (S) glycoprotein have been exploited for the treatment of severe COVID-19. In this study, we evaluated the immune-regulatory features of two neutralizing anti-S...
5.
Vacca F, Cardamone D, Andreano E, Medini D, Rappuoli R, Sala C
Sci Rep
. 2024 Feb;
14(1):4807.
PMID: 38413727
Antimicrobial resistance (AMR) is nowadays a global health concern as bacterial pathogens are increasingly developing resistance to antibiotics. Monoclonal antibodies (mAbs) represent a powerful tool for addressing AMR thanks to...
6.
Grauslund L, Stander S, Veggi D, Andreano E, Rand K, Norais N
Mol Cell Proteomics
. 2024 Feb;
23(3):100734.
PMID: 38342408
Antigen-antibody interactions play a key role in the immune response post vaccination and the mechanism of action of antibody-based biopharmaceuticals. 4CMenB is a multicomponent vaccine against Neisseria meningitidis serogroup B...
7.
Johnson N, Wall S, Kramer K, Holt C, Periasamy S, Richardson S, et al.
bioRxiv
. 2024 Jan;
PMID: 38293237
Three coronaviruses have spilled over from animal reservoirs into the human population and caused deadly epidemics or pandemics. The continued emergence of coronaviruses highlights the need for pan-coronavirus interventions for...
8.
Paciello I, Maccari G, Pantano E, Andreano E, Rappuoli R
Proc Natl Acad Sci U S A
. 2024 Jan;
121(3):e2314730121.
PMID: 38198525
A growing body of evidence shows that fragment crystallizable (Fc)-dependent antibody effector functions play an important role in protection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. To unravel...
9.
Silva-Moraes V, Souquette A, Sautto G, Paciello I, Antonelli G, Andreano E, et al.
Immunohorizons
. 2023 Oct;
7(10):635-651.
PMID: 37819998
Spike-encoding mRNA vaccines in early 2021 effectively reduced SARS-CoV-2-associated morbidity and mortality. New booster regimens were introduced due to successive waves of distinct viral variants. Therefore, people now have a...
10.
Stazzoni S, Troisi M, Abbiento V, Sala C, Andreano E, Rappuoli R
Front Microbiol
. 2023 Sep;
14:1243427.
PMID: 37655342
(gonococcus) is an obligate human pathogen and the etiological agent of the sexually transmitted disease gonorrhea. The rapid rise in gonococcal resistance to all currently available antimicrobials has become a...